While there is full agreement that an AIDS vaccine will be vital in combatting AIDS in the future, there appears to be a shift in approach to vaccine development. Current funding for vaccine research
is tightening, while simultaneously many advocates are calling for new "market incentives" to encourage private sector involvement. The United Kingdom, currently heading the G8, has said that advance purchase commitments would
be on the agenda in June's meeting in
Gleneagles. As background on this issue, the
Center for Global Development has published an excellent primer on Advance Markets for Vaccines in two forms: a consultation draft (which will be followed by a full book) and a 3 page brief.